Pharmacy Policies
These pharmacy policies apply to our Ohio Medicaid plan.
The policies below are in PDF format. If you do not have Adobe Acrobat Reader, you may download it here.
Current Pharmacy Policies
CareSource Managed Policies
The following medications are managed under the Medical Benefit at CareSource or are medications not included in the Ohio Department of Medicaid’s current Unified Preferred Drug List. Therefore, these medications utilize criteria outlined within the following policies:
-
List of CareSource managed drugs
A
- Abecma (idecabtagene vicleucel)
- Acthar Gel (repository corticotropin injection)
- Adakveo (crizanlizumab-tmca)
- Adbry (tralokinumab-ldrm)
- Aduhelm (aducanumab-avwa)
- Aldurazyme (laronidase)
- Alpha-1 Proteinase Inhibitors
- Amondys 45 (casimersen)
- Apretude (cabotegravir extended-release)
- Arcalyst (Rilonacept)
B
C
D
E
- Egrifta SV (tesamorelin)
- Elaprase (idursulfase)
- Emflaza (deflazacort)
- Empaveli (pegcetacoplan)
- Enspryng (satralizumab-mwge)
- Entyvio (vedolizumab)
- ENZYME REPLACEMENT THERAPY (ERT) FOR GAUCHER DISEASE: Cerezyme (imiglucerase), Elelyso (taliglucerase alfa), Vpriv (velaglucerase alfa)
- Esbriet (pirfenidone)
- Euflexxa (sodium hyaluronate)
- Evenity (romosozumab-aqqg)
- Evkeeza (evinacumab-dgnb)
- Evrysdi (risdiplam)
- Exondys 51 (eteplirsen)
- Eylea (aflibercept)
F
G
H
I
J
K
L
M
- MACI (autologous cultured chondrocytes)
- Macrilen (macimorelin)
- Macugen (pegaptanib)
- medicaid-oh-policy-pharmacy-aduhelm-12142021
- Mepsevii (vestronidase alfa-vjbk)
- Monovisc (sodium hyaluronate)
- Mulpleta (lusutrombopag)
- Myalept (metreleptin)
- Mycapssa (octreotide)
- Myfembree (relugolix, estradiol, and norethindrone acetate)
- Myobloc (rimabotulinumtoxinB)
N
O
P
Q
R
- Radicava (edaravone injection)
- Ravicti (glycerol phenylbuytyrate)
- Reblozyl (luspatercept-aamt)
- Remicade (infliximab)
- Renflexis (infliximab-abda)
- Retisert (fluocinolone acetonide)
- Rezurock (belumosudil)
- Rituxan (rituximab)
- Ruconest (C1 esterase inhibitor (recombinant))
- Ruzurgi (amifampridine)
- Ryplazim (plasminogen, human-tvmh)
S
- Saphnelo (anifrolumab-fnia)
- Scenesse (Afamelanotide)
- Signifor, Signifor LAR (pasireotide)
- Simponi Aria (golimumab)
- Skytrofa (lonapegsomatropin)
- Sogroya (somapacitan-beco)
- Soliris (eculizumab)
- Somavert (pegvisomant)
- Spinraza (nusinersen)
- Spravato (esketamine)
- Strensiq (asfotase alfa)
- Suboxone (buprenorphine and naloxone) sublingual film, for sublingual or buccal use
- Subutex (buprenorphine)
- Supartz FX (sodium hyaluronate)
- Supprelin LA (histrelin acetate)
- Susvimo (ranibizumab)
- Synagis (palivizumab)
- Synvisc (sodium hyaluronate)
- Synvisc-One (sodium hyaluronate)
T
U
V
W
X
Y
Z
Ohio Department of Medicaid Unified Preferred Drug List
The following medications are managed under the Pharmacy Benefit, or Pharmacy and Medical Benefit both, at CareSource and are found within the Ohio Department of Medicaid’s current Unified Preferred Drug List. Therefore, these medications utilize criteria outlined within the Ohio Unified Preferred Drug List. Prescribers can access the UPDL documents online through ODM’s website by viewing the UPDL and UPDL criteria.
-
List of drugs with criteria outlined in the UPDL
For a complete description of criteria correlated to the medications below, please view the Ohio Unified Preferred Drug List found here:
A
• Actemra (tocilizumab) • Aimovig (erenumab-aooe) • Ajovy (fremanezumab-vfrm) • Ampyra (Dalfampridine) • Aranesp (darbepoetin alfa) • Aubagio (teriflunomide) • Avonex (interferon beta-1a)
B
• Betaseron (interferon beta-1b) • Bethkis (tobramycin inhalation solution) • Biologic Cholesterol Agents
C
• Cayston (aztreonam inhalation solution) • Cimzia (certolizumab pegol) • Cosentyx (secukinumab)
D
• Daklinza (daclatasvir) • Dupixent (dupilumab)
E
• Emgality (galcanezumab-gnlm) • Enbrel (etanercept) • Epclusa (sofosbuvir/velpatasvir) • Epidiolex (cannabidiol) • Epogen (epoetin alfa) • Extavia (interferon beta-1b)
G
• Genotropin (somatropin) • Gilenya (fingolimod) • Granix (tbo-filgrastim)
H
• Harvoni (ledipasvir/sofosbuvir) • Humatrope (somatropin) • Humira (adalimumab)
K
• Kalydeco (ivacaftor) • Kevzara (sarilumab) • Kineret (anakinra) • Kitabis Pak (tobramycin inhalation solution)
L
• Leukine (sargramostim)
M
• Mavenclad (cladribine) • Mavyret (glecaprevir and pibrentasvir) • Mayzent (siponimod)
N
• Neupogen (filgrastim) • Norditropin (somatropin) • Nutropin AQ (somatropin)
O
• Olumiant (baricitinib) • Omnitrope (somatropin) • Orencia (abatacept) • Orkambi (lumacaftor/ivacaftor) • Otezla (apremilast)
P
• Pegasys (peginterferon alfa-2a) • Pegylated and Non-Pegylated Interferon • Plegridy (peginterferon beta-1a) • Procrit (epoetin alfa) • Pulmonary Arterial Hypertension
R
• Rebif (interferon beta-1a) • Relistor (methylnaltrexone)
S
• Sabril (vigabatrin) • Saizen (somatropin) • Serostim (somatropin) • Siliq (brodalumab) • Simponi (golimumab) • Skyrizi (risankizumab-rzaa) • Sovaldi (sofosbuvir) • Sublocade (buprenorphine extended-release) injection, for subcutaneous use • Symdeko (tezacaftor/ivacaftor)
T
• Taltz (ixekizumab) • Tecfidera (dimethyl fumarate) • Tobi (tobramycin inhalation solution) • Tremfya (guselkumab)
V
• Varubi (rolapitant) • Vosevi (sofosbuvir/velpatasvir/voxilaprevir)
X
• Xeljanz/Xeljanz XR (tofacitinib)
Z
• Zarxio (filgrastim-sndz) • Zepatier (grazoprevir/elbasvir) • Zomacton (somatropin)